Memphis Pharmaceuticals (MPCI.CA) - Central Auditing Organization's Report
Company Name : Memphis Pharmaceuticals
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
Central Auditing Organization's report on the financial statements for the fiscal year ended on 30/09/2025
The Central Auditing Organization's Report (3,880 KB)
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
Central Auditing Organization's report on the financial statements for the fiscal year ended on 30/09/2025
The Central Auditing Organization's Report (3,880 KB)
Comments